https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/gene-therapy-trial-patients-fanconi-anaemia-open-gosh/
Gene therapy trial for patients with Fanconi anaemia to open at GOSH
22 Mar 2016, 5:24 p.m.
A clinical trial is to open at Great Ormond Street Hospital (GOSH) that will test the use of gene therapy during transplantation for the treatment of young people with Fanconi anaemia. The trial will be led by Dr Claire Booth, Dr Phil Ancliff and Professor Adrian Thrasher – who is the Gene, stem and cellular therapies Theme Lead at the Great Ormond Street BRC.
Fanconi anaemia is a life-limiting, inherited haematological disorder which causes bone marrow failure in childhood as well as other serious complications. Children can be treated with a bone marrow transplant but the success of this procedure depends on finding a well matched donor for the patient.
The clinical trial due to open at GOSH in the coming months will assess whether gene therapy could offer hope to children lacking a suitable donor for transplant.
Researchers will make use of the BRC-funded GMP facility to genetically modify the patient’s own stem cells during the trial.
Shaping better research from the start
At GOSH, patient and public involvement is helping researchers to ask the right question, right from the start.
Research internships: building a more inclusive pipeline into clinical academia
Through our Research Hospital Internship programme, the NIHR GOSH Biomedical Research Centre (BRC) is enabling healthcare professionals from diverse backgrounds to take their first steps into research.
Working together to transform research
Our Highlight Report shines a spotlight on some of our brightest and best work in 2025-26. Our Impact report brings together a series of case studies and reflections that showcase the breadth and depth of PPIE across our organisation.
UK-wide excellence in paediatrics
Through the Paediatric Excellence Initiative, the NIHR GOSH Biomedical Research Centre is building a connected, collaborative UK-wide system to accelerate paediatric research.